Mutually exclusive protein folding
互斥的蛋白质折叠
基本信息
- 批准号:6906434
- 负责人:
- 金额:$ 27.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-07-01 至 2008-06-30
- 项目状态:已结题
- 来源:
- 关键词:Escherichia coliallosteric siteantiinfective agentsantineoplasticsbacterial proteinsbinding sitesbioengineering /biomedical engineeringbiophysicsbiotechnologycell typechimeric proteinsconformationcytotoxicitydrug design /synthesis /productionmethod developmentmicroorganism disease chemotherapyneoplasm /cancer chemotherapypeptide chemical synthesisphysical modelprotein engineeringprotein foldingprotein structurethermodynamicstissue /cell cultureubiquitinvirus diseases
项目摘要
DESCRIPTION (provided by applicant): Many proteins are built from structurally distinct subunits that communicate with each other by means of a conformational change in order to achieve overall function. The primary goal of this project is to create a new class of bi-functional, two-domain proteins that capture the properties of this conformationally-driven allosteric switch. This aim will be accomplished by implementing the novel concept of mutually exclusive folding, in which the free energy stored in the native structure of one subunit is used to drive unfolding of another subunit within the same molecule. A fusion protein is created by inserting one protein into a surface loop of another. A topological constraint causes the two domains to engage in a thermodynamic tug-of-war, from which only one can emerge in its folded state at any given-time. They cannot simultaneously exist in their native states. This conformational equilibrium cooperative, reversible, and controllable by ligand binding serves as a model for the coupled binding and folding mechanism widely used to mediate protein-protein interactions and cellular signaling processes. The unique properties afforded by mutually exclusive folding will be additionally exploited to develop two new applications. The first is an Escherichia coil based approach for rapidly selecting ultra-stable protein variants in vivo. The mutually exclusive folding design, combined with the use of a cytotoxic enzyme for one of the protein domains, results in a selection method of unprecedented versatility and throughput. The second is a class of cytotoxic enzymes that kills specific cell types. By virtue of the mutually exclusive folding design, activity of the catalytic domain is turned on or off by binding of a ligand to an engineered regulatory domain. Ligand binding domains from any one of a large number of proteins can perform this function. This switching mechanism forms the basis for developing cytotoxic proteins that are activated by a wide variety of cell-specific effector molecules, and can thus target cancerous or virally infected cells for destruction.
描述(由申请人提供):许多蛋白质是由结构不同的亚基构建的,这些亚基通过构象变化相互通讯以实现整体功能。该项目的主要目标是创建一类新型双功能、双结构域蛋白质,以捕获这种构象驱动的变构开关的特性。这一目标将通过实施互斥折叠的新概念来实现,其中存储在一个亚基天然结构中的自由能用于驱动同一分子内另一个亚基的展开。融合蛋白是通过将一种蛋白质插入另一种蛋白质的表面环而产生的。拓扑约束导致这两个域陷入热力学拉锯战,在任何给定时间只有一个域能够以折叠状态出现。他们不能同时存在于各自的原生状态。这种构象平衡协同、可逆且可通过配体结合控制,作为耦合结合和折叠机制的模型,广泛用于介导蛋白质-蛋白质相互作用和细胞信号传导过程。相互排斥的折叠所提供的独特特性将被另外利用来开发两种新的应用。第一种是基于大肠杆菌的方法,用于在体内快速选择超稳定的蛋白质变体。相互排斥的折叠设计,结合对其中一个蛋白质结构域使用细胞毒性酶,产生了一种具有前所未有的多功能性和通量的选择方法。第二种是一类杀死特定细胞类型的细胞毒性酶。凭借相互排斥的折叠设计,催化结构域的活性通过配体与工程化调节结构域的结合来打开或关闭。来自大量蛋白质中任何一种的配体结合域都可以执行此功能。这种转换机制构成了开发细胞毒性蛋白的基础,这些蛋白被多种细胞特异性效应分子激活,因此可以靶向癌细胞或病毒感染的细胞进行破坏。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(2)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEWART N LOH其他文献
STEWART N LOH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEWART N LOH', 18)}}的其他基金
Combining protein and DNA engineering to create bioswitches
结合蛋白质和 DNA 工程来创建生物开关
- 批准号:
10561100 - 财政年份:2022
- 资助金额:
$ 27.36万 - 项目类别:
Combining protein and DNA engineering to create bioswitches
结合蛋白质和 DNA 工程来创建生物开关
- 批准号:
10707393 - 财政年份:2022
- 资助金额:
$ 27.36万 - 项目类别:
Mechanism and detection of LECT2 amyloidosis
LECT2淀粉样变性的机制及检测
- 批准号:
10475334 - 财政年份:2021
- 资助金额:
$ 27.36万 - 项目类别:
Targeted Destruction of HIV and HIV-Infected Cells by an Engineered Ribonuclease
通过工程核糖核酸酶靶向破坏 HIV 和 HIV 感染细胞
- 批准号:
7414887 - 财政年份:2007
- 资助金额:
$ 27.36万 - 项目类别:
Targeted Destruction of HIV and HIV-Infected Cells by an Engineered Ribonuclease
通过工程核糖核酸酶靶向破坏 HIV 和 HIV 感染细胞
- 批准号:
7283356 - 财政年份:2007
- 资助金额:
$ 27.36万 - 项目类别:
相似国自然基金
靶向正构或变构位点的选择性PI3Kα抑制剂的设计、合成及抗肿瘤活性评价
- 批准号:22367006
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
靶向真菌FBA全新共价变构位点新型双功能共价抑制剂的发现及其机制研究
- 批准号:22377030
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
靶向SARS-CoV-2主蛋白酶二聚体界面新位点变构抑制剂的设计、合成与活性评价
- 批准号:22307067
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于靶蛋白BRD4变构位点的海洋抗炎小分子MBR19结构优化及作用机制研究
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
靶向FBPase共价变构新位点C128的新型共价抑制剂的合理设计、合成优化及其调控机理的研究
- 批准号:
- 批准年份:2021
- 资助金额:60 万元
- 项目类别:面上项目
相似海外基金
Structural and Functional Analysis of Nucleocytoplasmic Protein O-Glycosyltransferases in Plants
植物核胞质蛋白 O-糖基转移酶的结构和功能分析
- 批准号:
10648930 - 财政年份:2023
- 资助金额:
$ 27.36万 - 项目类别:
Allosteric regulation of lysine degradation as a novel pathophysiological mechanism in glutaric aciduria type 1
赖氨酸降解的变构调节作为 1 型戊二酸尿症的一种新的病理生理机制
- 批准号:
10720740 - 财政年份:2023
- 资助金额:
$ 27.36万 - 项目类别:
Understanding Essential Protein Dynamics through the Anharmonic Properties of Thermally Excited Vibrations
通过热激发振动的非简谐特性了解基本蛋白质动力学
- 批准号:
10566333 - 财政年份:2023
- 资助金额:
$ 27.36万 - 项目类别:
Function and Targeting of ETV6 in Ewing Sarcoma
ETV6 在尤文肉瘤中的功能和靶向
- 批准号:
10740562 - 财政年份:2023
- 资助金额:
$ 27.36万 - 项目类别:
Mechanistic dissection of allosteric modulation and nonproteolytic chaperone activity of human insulin-degrading enzyme
人胰岛素降解酶变构调节和非蛋白水解伴侣活性的机制剖析
- 批准号:
10667987 - 财政年份:2023
- 资助金额:
$ 27.36万 - 项目类别: